Desmoid tumor
ICD-10 D48.11 is a billable code used to indicate a diagnosis of desmoid tumor.
Desmoid tumors, also known as aggressive fibromatosis, are benign neoplasms that arise from the connective tissue, particularly the fascia and aponeurosis. These tumors are characterized by their infiltrative growth pattern and can occur in various anatomical locations, including the abdominal wall, extremities, and trunk. Although classified as benign, desmoid tumors exhibit a tendency for local recurrence and can cause significant morbidity due to their size and location. The etiology of desmoid tumors is not fully understood, but they are often associated with genetic conditions such as familial adenomatous polyposis (FAP). Clinically, patients may present with a palpable mass, pain, or functional impairment depending on the tumor's location. Imaging studies, including MRI and CT scans, are essential for diagnosis and assessing the extent of the tumor. Treatment options vary and may include surgical excision, observation, or pharmacological interventions such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies. Due to their uncertain behavior, ongoing surveillance is crucial to monitor for recurrence or progression, making accurate coding and documentation essential in managing these patients effectively.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with a palpable mass, pain, or functional impairment due to desmoid tumors.
Ensure accurate documentation of tumor size, location, and any surgical interventions performed.
Operative reports detailing excision margins and any complications.
Surgical intervention for desmoid tumors, particularly in cases of recurrence.
Document the rationale for surgical intervention versus observation.
Used when excising a desmoid tumor located in the thoracic region.
Operative report detailing the excision and margins.
Ensure the surgical approach is documented.
Desmoid tumors are benign but can be locally aggressive, leading to recurrence. Prognosis varies based on tumor location and treatment response.
